COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations. Cell Rep. 2021 07 27; 36(4):109433.
View in:
PubMed
subject areas
Antibodies, Neutralizing
Antibodies, Viral
Humans
Mutation
Peptidyl-Dipeptidase A
Protein Binding
Protein Domains
Spike Glycoprotein, Coronavirus
authors with profiles
Jakob Trimpert
Ulfert Rand
Maximilian Ruschig
Thomas Klünemann
Doris Meier
Maren Schubert
André Frenzel
Federico Bertoglio
Stefan Dübel
Joop van den Heuvel
Peggy Riese
Günter Roth
Sebastian Casu
Julia Adler
Hendrikus S P Garritsen
Philip Alexander Heine
Michael Hust
Allan Koch
Kristian Daniel Ralph Roth
Andreas Gerstner
Andreas Hermann
Viola Fühner
Susanne Zock-Emmenthal
Janin Korn
Stephan Steinke
Dorina Schäckermann
Leila Abassi
Marlies Becker
Margitta Scholz
Giulio Russo
M Zeeshan Chaudhry
Thomas Schirrmann
Nora Langreder
Kai-Thomas Schneider
Kathrin Eschke
Gustavo Marçal Schmidt Garcia Moreira
Esther Veronika Wenzel
Yeonsu Kim
Philipp Kuhn
Luka Cicin-Sain
Rico Ballmann